Clinical Oncology
Volume 21, Issue 1 , Pages 43-48 , February 2009

New Prognostic Index to Predict Survival in Patients with Cancer of Unknown Primary Site with Unfavourable Prognosis

  • D. Trivanović

      Affiliations

    • Department of Oncology, General Hospital Pula, Croatia
    • Corresponding Author InformationAuthor for correspondence: D. Trivanović, Department of Internal Medicine, General Hospital Pula, Negri 6, 52100 Pula, Croatia. Tel: +385-523-76263, 376-173; Fax: +385-523-93901.
    • ,
  • M. Petkovic

      Affiliations

    • Department of Radiotherapy and Oncology, University Hospital Rijeka, Croatia
    • ,
  • D. Stimac

      Affiliations

    • Department of Gastroenterology, University Hospital Rijeka, Croatia

Received 12 June 2008 ,Revised 1 September 2008 ,Accepted 25 September 2008.

  • Image Result

    Kaplan–Meier survival curves in three distinct patient subgroups: none or one adverse factor (n=29, median survival 420 days), two adverse factors (n=34, median survival 152 days), three or four adver

    Kaplan–Meier survival curves in three distinct patient subgroups: none or one adverse factor (n=29, median survival 420 days), two adverse factors (n=34, median survival 152 days), three or four adverse factors (n=82, median survival 60 days). The four adverse prognostic factors were elevated lactate dehydrogenase, prolonged QTc interval, Eastern Cooperative Oncology Group performance status≥2 and liver metastasis.

PII: S0936-6555(08)00404-4

doi: 10.1016/j.clon.2008.09.007

Clinical Oncology
Volume 21, Issue 1 , Pages 43-48 , February 2009

Article Tools

* Image Usage & Resolution